Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta

Hepatology

Volumn 44, Issue 3, 2006, Pages 713-720

  Niro, Grazia Anna ^a   Ciancio, Alessia ^b   Gaeta, Giovanni Battista ^c   Smedile, Antonina ^b   Marrone, Aldo ^c   Olivero, Antonella ^b   Stanzione, Maria ^c   David, Ezio ^b   Brancaccio, Giuseppina ^c   Fontana, Rosanna ^a   Perri, Francesco ^a   Andriulli, Angelo ^a   Rizzetto, Mario ^b  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIDEPRESSANT AGENT; HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE; PEGINTERFERON ALPHA2B; RIBAVIRIN; VIRUS RNA;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ARTHRALGIA; ARTICLE; CELLULITIS; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DELTA AGENT HEPATITIS; DEPRESSION; DRUG DOSE REGIMEN; DRUG SAFETY; FATIGUE; FEMALE; FOLLOW UP; HEADACHE; HEPATITIS DELTA VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INJECTION SITE REACTION; INSOMNIA; IRRITABILITY; MALE; MONOTHERAPY; NAUSEA; NEUTROPENIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PRURITUS; RESPIRATORY TRACT INFECTION; SIDE EFFECT; THROMBOCYTOPENIA; URINARY TRACT INFECTION;

ADULT; ANTIVIRAL AGENTS; BIOPSY; DRUG CARRIERS; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HEPATITIS D, CHRONIC; HEPATITIS DELTA VIRUS; HUMANS; INTERFERON ALFA-2B; MALE; MIDDLE AGED; RIBAVIRIN; RNA, VIRAL; TREATMENT OUTCOME;

EID: 33748947285     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21296     Document Type: Article

References (27)

1. Lau JY, Smith HM, Chaggar K, Hansen LJ, Portmann BC, Alexander GJ, Williams R. Significance of IgM anti-hepatitis D virus (HDV) in chronic HDV infection. J Med Virol 1991;33:273-276.
2. Rosina F, Conoscitore P, Cuppone R, Rocca G, Giuliani A, Cozzolongo R, et al. Changing pattern of chronic hepatitis D in southern Europe. Gastroenterology 1999;117:161-166
3. Gaeta GB, Stroffolini T, Chiaramonte M, Ascione T, Stornaiuolo G, Lobello S, et al. Chronic hepatitis D: a vanishing disease? An Italian multicenter study. HEPATOLOGY 2000;32:824-827.
4. Rosina F, Saracco G, Lattore V, Quartarone V, Rizzetto M, Verme G, et al. Alpha 2 recombinant Interferon in the treatment of chronic hepatitis delta virus (HDV) hepatitis. Prog Clin Biol Res 1987;234:299-303.
5. Farci P, Mandas A, Coiana A, Lai ME, Desmet V, Van Eyken P, et al. Treatment of chronic hepatitis D with interferon alpha-2a. N Engl J Med 1994;330:88-94.
6. Madejon A, Cotonat T, Bartolome J, Castillo I, Carreno V. Treatment of chronic hepatitis D virus infection with low and high doses of interferon-alpha 2a: utility of polymerase chain reaction in monitoring antiviral response. HEPATOLOGY 1994;19:1331-1336.
7. Lau DT, Kleiner DE, Park Y, Di Bisceglie AM, Hoofnagle JH. Resolution of chronic delta hepatitis after 12 years of interferon alfa therapy. Gastroenterology 1999;117:1229-33.
8. Farci P, Roskams T, Chessa L, Peddis G, Mazzoleni AP, Scioscia R, et al. Long-term benefit of interferon α therapy of chronic hepatitis D: regression of advanced hepatic fibrosis. Gastroenterology 2004;126:1740-1749.
9. Gaudin JL, Faure P, Godinot H, Gerard F, Trepo C. The French experience of treatment of chronic type D hepatitis with a 12 month course of IFN alpha-2b. Results of a randomized, controlled trial. Liver 1995;!15:45-52.
10. Rosina F, Conoscitore P, Smedile A, Mangia A, Borghesio E, Martinotti R, et al. Treatment of chronic hepatitis D with thymus-derived polipeptide thymic humoral factor-gamma 2: a pilot study. Dig Liver Dis 2002;34:285-289.
11. Yurdaydin C, Bozkaya H, Gurel S, Tillman HL, Asian M, Okcu-Heper A, et al. Famciclovir treatment of chronic delta hepatitis. J Hepatol 2002;37:266-271.
12. Niro GA, Ciancio A, Tillman HL, Lagget M, Olivero A, Perri F, et al. Lamivudine therapy in chronic delta hepatitis: a multicentre multicentre randomized-controlled pilot study. Aliment Pharmacol Ther 2005;22:227-232.
13. Rasshofer R, Choi S-S, Wolfl P, Roggendorf M. Interference of antiviral substances with replication of hepatitis delta virus RNA in primary woodchuck hepatocytes. Prog Clin Biol Res 1991;364:223-234.
14. Garripoli A, Di Marco V, Cozzolongo R, Costa C, Smedile A, Fabiano A, et al. Ribavirin treatment for chronic hepatitis D: a pilot study. Liver 1994;14:154-157.
15. Gunsar F, Akarca US, Ersoz G, Kobak AC, Karasu Z, Yuce G, et al. Two-year interferon therapy with or without ribavirin in chronic delta hepatitis. Antivir Ther 2005;10:721-726.
16. Smedile A, Lavarini C, Crivelli O, Raimondo G, Fassone M, Rizzetto M. Radioimmunoassay-detection of IgM antibodies to the HBV associated delta δ antigen: clinical significance in δ infection. J Med Virol 1982; 9:131-138.
17. Smedile A, Casey JL, Cote PJ, Durazzo M, Lavezzo B, Purcell RH, et al. Hepatitis D viremia following orthotopic liver transplantation involves a typical HDV virion with hepatitis B surface antigen envelope. HEPATOLOGY 1998;27:1723-1729.
18. Ishak KG. Pathologic features of chronic hepatitis. A review and update. Am J Clin Pathol 2000;113:40-55.
19. Marinucci G, Hassan G, Di Giacomo C, Barletteri A, Costa F, Rasshofer R, et al. Long term treatment of chronic delta hepatitis with alpha recombinant interferon. In: Gerin JL, Purcell RH, Rizzetto M, eds. The Hepatitis Delta Virus. New York: Wiley-Liss, 1991:405-410.
20. Rosina F, Pintus C, Meschievitz C, Rizzetto M. A randomized controlled trial of a 12 month course of recombinant human interferon alpha in chronic delta (type D) hepatitis: a multicenter Italian study. HEPATOLOGY 1991;13:1052-1056.
21. Lau JY, King R, Tibbs CJ, Catterall AP, Smith HM, Portman BC, et al. Loss of HBsAg with interferon alpha therapy in chronic hepatitis D virus infection. J Med Virol 1993;39:292-296.
22. Zavaglia C, Airoldi A, Pinzello G. Antiviral therapy of HBV- and HCV-induced liver cirrhosis. J Clin Gastroenterol 2000;30:234-241.
23. Carreno V, Marcellin P, Hadziyannis S, Salmeron J, Diago M, Kitis GE, et al. Retreatment of chronic hepatitis B e antigen-positive patients with recombinant interferon alfa-2a. The European Concerted Action on Viral Hepatitis (EUROHEP). HEPATOLOGY 1999;30:277-282.
24. Fontana RJ. Non responders to hepatitis C virus antiviral therapy: pegylated interferons and beyond. Gastroenterol Clin North Am 2004;33:527-547.
25. Marzano A, Ottobrelli A, Spezia C, Dazzano E, Sorenzo ML, Rizzetto M. Treatment of early chronic delta hepatitis with lymphoblastoid alpha Interferon: a pilot study. Italian J Gastroenterol 1992;24:119-121.
26. Niro GA, Gravinese E, Martini E, Garrubba M, Facciorusso D, Conoscitore P, et al. Clearance of hepatitis B surface antigen in chronic carriers with hepatitis delta antibodies. Liver 2001;21:254-259.
27. Battegay M, Simpson LH, Hoofnagle JH, Sallie R, Di Bisceglie AM. Elimination of hepatitis delta virus infection after loss of hepatitis B surface antigen in patients with chronic delta hepatitis. J Med Virol 1994;44:389-392.